IL2 and COVID-19: Early into the pandemic, those diagnosed with COVID-19 were found to display significantly elevated proinflammatory responses, including increased levels of IL-6, TNF, IL-2, IL-1β, IP-10, IFNγ, MCP1 and MIP1α [5],[99].